Request for Public Comments: 8 Nominations for RoC 10th

http://ntp.niehs.nih.gov/go/6511

[Federal Register: March 5, 2001 (Vol. 66, No. 43)]
[Notices]
[Pages 13334-13338]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

PUBLIC HEALTH SERVICE

National Toxicology Program; Call for Public Comments on 8 Nominations, Proposed for Listing in or Delisting from the Report on Carcinogens, Tenth Edition

Background

The National Toxicology Program (NTP) solicits final public comments on agents, substances, mixtures and exposure circumstances reviewed in 2000 for listing in or delisting from the Report on Carcinogens, Tenth Edition. This Report (previously known as the Annual Report on Carcinogens) is a Congressionally mandated listing of known human carcinogens and reasonably anticipated human carcinogens and its preparation is delegated to the National Toxicology Program by the Secretary, Department of Health and Human Services (DHHS). Section 301 (b) (4) of the Public Health Service Act, as amended, provides that the Secretary, (DHHS), shall publish a biennial report which contains a list of all substances (1) which either are known to be human carcinogens or may reasonably be anticipated to be human carcinogens; and (2) to which a significant number of persons residing in the United States (US) are exposed. The law also states that the reports should provide available information on the nature of exposures, the estimated number of persons exposed and the extent to which the implementation of Federal regulations decreases the risk to public health from exposure to these chemicals.

In 2000, eight nominations were reviewed for listing in the Tenth Report. This review included two Federal and one non-government, scientific peer reviews and public comment and review. The three scientific review committees evaluated all available data relevant to the criteria for inclusion of candidate nominations in the Report. The criteria used in the review process and a detailed description of the review procedures, including the steps in the current formal review process, can be obtained from the NTP Home Page website at http://ntp.niehs.nih.gov/ntp/ or by contacting: Dr. C. W. Jameson, National Toxicology Program, Report on Carcinogens, MD EC-14, P.O. Box 12233, Research Triangle Park, NC 27709; phone: (919) 541-4096, fax: (919) 541-0144, email: jameson@niehs.nih.gov.

Public Comment Requested

The nominations reviewed in 2000 are provided in the following table with their Chemical Abstracts Services (CAS) Registry numbers (where available) and the recommendations from the three scientific peer reviews of the nominations. The NTP will be making a final recommendation in 2001 for these eight nominations for listing in, or changing the current listing from reasonably anticipated to be a human carcinogento the known to be a human carcinogen category in the Tenth Report.

Background documents provided to the review committees and the public are available on the web in PDF-format at the address above. Hard copies of these documents are also available upon request. The NTP will review the recommendations from each of the review committees and consider the public comments received throughout the process in making decisions regarding the NTP recommendations to the Secretary, DHHS, for listing of the nominated substances in the Tenth Edition of the Report on Carcinogens. The NTP solicits final public comment to supplement any previously submitted comments or to provide comments for the first time on any substance in the following table. Comments will be accepted for 60 days from the publication date of this announcement and should be directed to Dr. C. W. Jameson at the address listed above. Individuals submitting public comments are asked to include relevant contact information [name, affiliation (if any), address, telephone, fax, and e-mail].

Attachment

Dated: February 21, 2001

Kenneth Olden, Ph. D.
Director
National Toxicology Program

[Billing Code 4140-01-P]

Summary of RG1¹, RG2² and NTP Board Subcommittee³ Recommendations
for the Agents, Substances, Mixtures or Exposure Circumstances Reviewed
in 2000 for Listing in, Delisting from, or Upgrading in the Report on Carcinogens⁴, 10th Edition

NOMINATION/ CAS NUMBER	PRIMARY USES OR EXPOSURES	RG1 ACTION	RG2 ACTION	NTP BOARD SUBCOMMITTEE ACTION
Broad Spectrum UV Radiation (UVR) and UVA, and UVB, and UVC	Solar and artificial sources of ultraviolet radiation	Motion to list UVR as known to be a human carcinogen passed by unanimous vote (6/0). Motion to list UVA, UVB and UVC as reasonably anticipated to be human carcinogens passed by unanimous vote (6/0).	Motion to list UVR as known to be a human carcinogen passed by unanimous vote (8/0) Motion to list UVA, UVB and UVC as reasonably anticipated to be human carcinogens passed by unanimous vote (8/0).	Motion to list UVR as known to be a human carcinogen passed by unanimous vote (10/0). Motion to list UVA as reasonably anticipated to be human carcinogen passed by unanimous vote (10/0). Motion to list UVB as reasonably anticipated to be human carcinogen passed by vote of 7 yes to 3 no. Negative votes (3) cast because members felt data meets criteria to list as known human carcinogen. Motion to list UVC as reasonably anticipated to be human carcinogen passed by vote of 9 yes to 1 no. Negative vote (1) cast because member felt insufficient human data to list as reasonably anticipated carcinogen.
Chloramphenicol (56-75-7)	Chloramphenicol has been used as an antibiotic since the 1950s.	Motion to list Chloramphenicol as reasonably anticipated to be human carcinogen passed by unanimous vote (7/0).	Motion to list Chloramphenicol as reasonably anticipated to be human carcinogen passed by vote of 7 yes to 0 no with 1 abstention . Abstention (1) was because member felt data concerning link between aplastic anemia and leukemia was not compelling.	Motion to list Chloramphenicol as reasonably anticipated to be human carcinogen passed by unanimous vote (10/0).
Estrogens, Steroidal	Estrogens are widely used in post-menopausal therapy and in oral contraceptives for women.	Motion to list Steroidal Estrogens as known to be a human carcinogen passed by unanimous vote (7/0).	Motion to list Steroidal Estrogens as known to be a human carcinogen passed by unanimous vote (8/0).	Motion to list Steroidal Estrogens as known to be a human carcinogen passed by a vote of 8 yes to 1 no. Negative vote (1) cast because member felt insufficient human data to list all steroidal estrogens in the Report.
Methyleugenol (93-15-2)	Methyleugenol are flavoring agents used in jellies, baked goods, nonalcoholic beverages, chewing gum, candy, and ice cream. Also used as fragrance for many perfumes, lotions, detergents and soaps.	Motion to list Methyleugenol as reasonably anticipated to be human carcinogen passed by unanimous vote (7/0).	Motion to list Methyleugenol as reasonably anticipated to be human carcinogen passed by unanimous vote (8/0).	Motion to list Methyleugenol as reasonably anticipated to be human carcinogen passed by a vote of 9 yes to 1 no. Negative vote (1) cast because member felt insufficient human data to list in the Report.
Nickel (metallic) and Certain Nickel Alloys	Metallic Nickel and Nickel Alloys have been used in commercial applications for over 100 years.	Motion to list Metallic Nickel and Certain Nickel alloys as reasonably anticipated to be human carcinogen passed by a vote of 6 yes to 2 no. Negative votes (2) cast because members did not agree with the use of term "certain" in the listing of Nickel alloys.	Motion to list Metallic Nickel as reasonably anticipated to be human carcinogen passed by a vote of 7 yes to 1 no. Negative vote (1) cast because member felt that animal data not persuasive to list in the Report as reasonably anticipated human carcinogens because of inappropriate routes of exposure. Motion not to list Certain Nickel Alloys in RoC was passed by a vote of 6 yes to 2 no. Negative votes (2) cast because members felt data meets criteria to list as reasonably anticipated to be a human carcinogen.	Motion to list Metallic Nickel as reasonably anticipated to be human carcinogen passed by a vote of 7 yes to 3 no. Negative votes (3) cast because members felt that the human and animal data not persuasive to list in the Report as reasonably anticipated human carcinogens. Motion to list Certain Nickel Alloys as reasonably anticipated to be human carcinogen was defeated by a vote of 3 yes to 7 no. in RoC. Negative votes (7) cast because members felt available data not persuasive to list in the Report as reasonably anticipated human carcinogens. Motion not to list Certain Nickel Alloys in RoC was passed by a vote of 9 yes to 1 no. Negative votes (1) cast because member felt data meets criteria to list as reasonably anticipated to be a human carcinogen.
Talc (14807-96-6) Asbestiform and Non-Asbestiform	Both Asbestiform talc (i.e. talc containing asbestiform fibers) and non-asbestiform talc (i.e. talc not containing asbestiform fibers) occur in various geological settings around the world. Occupational exposure to both forms occurs during mining, milling, and processing. Exposure to non-asbestiform talc by the general population occurs through the use of products such as cosmetics.	Motion to list Talc containing asbestiform fibers as known to be a human carcinogen passed by unanimous vote (7/0). Motion to list Talc not containing asbestiform fibers as reasonably anticipated to be a human carcinogen passed by a vote of 6 yes to 1 no. Negative vote (1) cast because member questioned the biological plausibility of talc use causing ovarian neoplasms in women.	Motion to list Talc containing asbestiform fibers as known to be a human carcinogen was defeated by a vote of 2 yes to 6 no. Negative votes (6) cast because members felt human data were not sufficient to list as known human carcinogen because asbestiform fibers were not considered to include asbestos contamination. Motion to list Talc containing asbestiform fibers as reasonably anticipated to be a human carcinogen passed by a vote of 6 yes to 2 no. Negative vote (1) cast because member felt data sufficient to list as a known human carcinogen. Other negative vote (1) cast because member felt evidence not adequate to list in the Report. Motion to list Talc not containing asbestiform fibers as reasonably anticipated to be a human carcinogen passed by a vote of 7 yes to 1 no. Negative vote (1) cast because member felt animal data not sufficient and human data confounded because of the uncertainty of possible contamination of talc with asbestos.	Motion to list Talc containing asbestiform fibers as reasonably anticipated to be a human carcinogen resulted in a tie vote (5 yes to 5 no). Negative votes (4) cast because members felt human and animal data not sufficient to list in Report. Other negative (1) cast because member felt action should be deferred. Motion not to list talc not containing asbestiform fibers as reasonably anticipated to be a human carcinogen passed by a vote of 7 yes to 3 no. Negative votes cast either because the member felt that data meets criteria to list talc not containing asbestiform fibers as reasonably anticipated to be a human carcinogen or that the ovarian cancer studies should have been considered in the evaluation. The Subcommittee did not consider the ovarian cancer studies in the evaluation of talc not containing asbestiform fibers because it was unclear if the talc used in these studies might have been contaminated with asbestos.
Trichloroethylene (TCE) (79-01-6)	Trichloroethylene is widely used as a solvent with 80-90% used worldwide for degreasing metals.	Motion to list TCE as known to be a human carcinogen passed by unanimous vote (7/0).	Motion to list TCE as known to be a human carcinogen was defeated by a vote of 3 yes to 4 no. Negative votes (4) cast because members felt the human data did not meet the criteria for listing as a known human carcinogen because the exposures in the human studies may not have been specific for TCE.	Motion that the listing of TCE should remain as reasonably anticipated to be a human carcinogen passed by a vote of 9 yes to 1 no. Negative vote (1) because member felt human data sufficient to list as a known human carcinogen.
Wood Dust	It is estimated that at least two million people are routinely exposed occupationally to wood dust worldwide. Non-occupational exposure also occurs. The highest exposures have generally been reported in wood furniture and cabinet manufacture, especially during machine sanding and similar operations.	Motion to list Wood Dust as known to be a human carcinogen passed by unanimous vote (8/0).	Motion to list Wood Dust as known to be a human carcinogen passed by unanimous vote (7/0).	Motion to list Wood Dust as known to be a human carcinogen passed by unanimous vote (8/0).

¹The NIEHS Review Committee for the Report on Carcinogens (RG1)

²The NTP Executive Committee^* Interagency Working Group for the Report on Carcinogens (RG2)

^*Agencies from the NTP Executive Committee represented on RG2 include: Agency for Toxic Substances and Disease Registry (ATSDR), Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), National Center for Environmental Health of the Centers for Disease Control and Prevention (NCEH/CDC), National Center for Toxicological Research of the Food and Drug Administration (NCTR/FDA), National Institute for Occupational Safety and Health/CDC (NIOSH/CDC), Occupational Safety and Health Administration (OSHA), National Cancer Institute of the National Institutes of Health (NCI/NIH), and National Institute of Environmental Health Sciences/NIH(NIEHS/NIH)

³The NTP Board of Scientific Counselors Report on Carcinogens Subcommittee (the External Peer Review Group)

⁴ RoC - Report on Carcinogens

Web page last updated on October 04, 2004